William Blake is the Chief Technology Officer at Sherlock Biosciences. Before assuming his position, Will joined the Wyss Institute to guide strategy and business development in the areas of cellular engineering and synthetic biology. Previously, Will was on the founding team of GreenLight Biosciences where he led the development of novel cell-free manufacturing technologies and scientific partnership strategy as Vice President of Research and Development. Prior to that, Will developed DNA assembly technologies and managed collaborative research projects at Codon Devices, an early synthetic biology company. Will is an author and inventor on scientific publications and patents in the fields of synthetic biology, cell engineering, and cell-free systems. Will holds a Ph.D. in Bioinformatics and an M.S. in Biomedical Engineering from Boston University, and earned his B.S. in Biomedical Engineering from The Johns Hopkins University.